Search Results - "Naluyima, Prossy"
-
1
Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, Uganda
Published in Emerging infectious diseases (01-07-2024)“…At 3 severe infection cohort sites in Uganda, Orientia seropositivity was common. We identified 4 seroconversion cases and 1 PCR-positive case. These results…”
Get full text
Journal Article -
2
High frequency of HIV precursor-target-specific B cells in sub-Saharan populations
Published in Cell reports (Cambridge) (26-12-2023)“…HIV gp120 engineered outer domain germline-targeting version 8 (eOD-GT8) was designed specifically to engage naive B cell precursors of VRC01-class antibodies…”
Get full text
Journal Article -
3
The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research
Published in PLoS neglected tropical diseases (01-12-2019)“…Following the 2013-2016 Ebola virus outbreak in West Africa, numerous groups advocated for the importance of executing clinical trials in outbreak settings…”
Get full text
Journal Article -
4
Sex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan Populations
Published in PloS one (05-01-2016)“…Management of patient care and interpretation of research data require evaluation of laboratory results in the context of reference data from populations with…”
Get full text
Journal Article -
5
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4 + T-cell activation/ exhaustion
Published in BMC complementary and alternative medicine (09-04-2021)“…In Sub-Saharan Africa, herbal therapy continues to be utilized for HIV-1 disease management. However, the therapeutic benefits of these substances remain…”
Get full text
Journal Article -
6
Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans
Published in PloS one (19-04-2011)“…HIV-1 disease progression is associated with persistent immune activation. However, the nature of this association is incompletely understood. Here, we…”
Get full text
Journal Article -
7
Quality Monitoring of HIV-1-Infected and Uninfected Peripheral Blood Mononuclear Cell Samples in a Resource-Limited Setting
Published in Clinical and Vaccine Immunology (01-06-2010)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
8
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa
Published in Clinical infectious diseases (15-10-2024)“…Shorter prophylactic vaccine schedules may offer more rapid protection against Ebola in resource-limited settings. This randomized, observer-blind,…”
Get full text
Journal Article -
9
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial
Published in The Lancet infectious diseases (01-12-2023)“…Sudan Ebola virus can cause severe viral disease, with an average case fatality rate of 54%. A recent outbreak of Sudan Ebola virus in Uganda caused 55 deaths…”
Get full text
Journal Article -
10
Sudan Virus Disease among Health Care Workers, Uganda, 2022
Published in The New England journal of medicine (18-07-2024)“…An Ebola outbreak occurred in Uganda in 2022. This letter reports transmission to health care workers in the nosocomial setting…”
Get full text
Journal Article -
11
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without Human Immunodeficiency Virus in Africa
Published in Clinical infectious diseases (28-08-2024)“…Abstract Background Shorter prophylactic vaccine schedules may offer more rapid protection against Ebola in resource-limited settings. Methods This randomized,…”
Get full text
Journal Article -
12
Transient Reductions in Human Immunodeficiency Virus (HIV) Clinic Attendance and Food Security During the Coronavirus Disease 2019 (COVID-19) Pandemic for People Living With HIV in 4 African Countries
Published in Clinical infectious diseases (16-11-2021)“…Abstract The coronavirus disease 2019 (COVID-19) pandemic and associated public health responses have disrupted daily living activities with economic and…”
Get full text
Journal Article -
13
Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria
Published in Clinical infectious diseases (10-09-2022)“…Introduction of antiretroviral therapy (ART) has been associated with a decline in human immunodeficiency virus (HIV)-related mortality, although HIV remains a…”
Get full text
Journal Article -
14
Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project
Published in African health sciences (01-08-2022)“…Introduction: Infectious diseases and neglected tropical diseases continue to be a major challenge in resource limited settings, causing significant morbidity…”
Get full text
Journal Article -
15
Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
Published in The Journal of infectious diseases (15-05-2015)“…Background. Human immunodeficiency virus (HIV)-associated cryptococcal meningitis (CM) is characterized by high fungal burden and limited leukocyte trafficking…”
Get full text
Journal Article -
16
Terminal Effector CD8 T Cells Defined by an IKZF2 + IL-7R - Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity
Published in The Journal of immunology (1950) (15-10-2019)“…HIV-1 infection expands large populations of late-stage differentiated CD8 T cells that may persist long after viral escape from TCR recognition. In this…”
Get full text
Journal Article -
17
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG
Published in Virology journal (29-06-2024)“…The magnitude of the HIV-1 epidemic in Nigeria is second only to the subtype C epidemic in South Africa, yet the subtypes prevalent in Nigeria require further…”
Get full text
Journal Article -
18
-
19
Ontogeny of CD4⁺ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1–Exposed Ugandan Infants
Published in The Journal of infectious diseases (01-02-2017)“…Background. Among infants exposed to human immunodeficiency virus (HIV) type 1, mixed breastfeeding is associated with higher postnatal HIV-1 transmission than…”
Get full text
Journal Article -
20
Terminally differentiated CD8 effector T cells have NK-like features and are potent mediators of HIV-specific ADCC
Published in The Journal of immunology (1950) (01-05-2017)“…Abstract Chronic viral infection and persistent antigenic stimulation is associated with a rise of late-stage differentiated CD8 T cells including a unique…”
Get full text
Journal Article